Skip to main content
Equibles
ZTS logo

ZTS · Zoetis Inc. · Investor Relations

Track ZTS — free

Use ZTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ZTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$83.82 +0.86 (+1.04%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$34.06B
Shares
406.32M
Volume · Nov 13 3.15M Avg daily vol (3M) 4.53M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-16 14:00 UTC Jefferies Global Healthcare Conference in London Conference

Recent news

Date Headline
2026-11-11 Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis
2026-11-10 Zoetis to Participate in the Jefferies Global Healthcare Conference in London
2026-11-05 Zoetis Announces Third Quarter 2026 Results; Highlights Progress Advancing Innovation Across Diversified Portfolio and Narrows Full Year 2026 Revenue Guidance, Raises Full Year 2026 Adjusted EPS Guidance
2026-10-20 Zoetis Receives FDA Approval for Convenia® RTU for Dogs (cefovecin injectable suspension), Helping More Medium and Large Dogs Access Single-Injection Treatment
2026-10-13 Zoetis Appoints Iris Knobloch to its Board of Directors
2026-10-08 Zoetis Declares Fourth Quarter 2026 Dividend
2026-10-06 New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus¹
2026-09-24 Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
2026-09-02 Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
2026-08-13 Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
2026-08-06 Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer
2026-08-06 Zoetis Announces Second Quarter 2026 Results
2026-07-22 Zoetis Launches Portela® (relfovetmab) in Canada and the European Union
2026-07-15 Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union
2026-07-14 Zoetis Announces Agreement to Acquire VitalRADS, Accelerating Diagnostic Capabilities
2026-07-07 Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND
2026-06-25 Zoetis to Host Webcast and Conference Call on Second Quarter 2026 Financial Results
2026-06-04 Zoetis Releases 2025 Sustainability Report: Advancing Sustainability in Animal Health for a Better Future
2026-06-04 Zoetis Shares Resources and Tips for New World Screwworm Response and Management
2026-05-21 Zoetis to Participate in Upcoming Investor Conferences
2026-05-20 Zoetis Declares Third Quarter 2026 Dividend
2026-05-07 Zoetis Announces First Quarter 2026 Results
2026-04-02 Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results
2026-03-12 Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum
2026-03-05 Zoetis to Participate in Upcoming Investor Conferences

Past events

Date Event Type
2026-11-05 Zoetis Inc. Q3 FY2026 Earnings Call Earnings call
2026-09-14 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-08-06 Zoetis Inc. Q2 FY2026 Earnings Call Earnings call
2026-06-02 William Blair 46th Annual Growth Stock Conference Conference
2026-05-28 Stifel 2026 Jaws and Paws Conference Conference
2026-05-20 2026 Annual Meeting of Shareholders Shareholder meeting
2026-05-07 Zoetis Inc. Q1 FY2026 Earnings Call Earnings call
2026-03-17 KeyBanc Capital Markets Healthcare Forum Event
2026-03-10 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-09 Leerink Global Healthcare Conference Conference
2026-02-26 Bank of America Securities 2026 Animal Health Summit Event
2026-02-12 Q4 Earnings conference call (announced in 8-K) Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-04 Piper Sandler 37th Annual Healthcare Conference Conference
2025-12-02 Zoetis Innovation Webcast Webcast
2025-11-04 Zoetis Quarterly Corporate Performance - Third Quarter 2025 Event
2025-09-08 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-05 Zoetis Quarterly Corporate Performance - Second Quarter 2025 Event
2025-06-03 William Blair 45th Annual Growth Stock Conference Conference
2025-05-29 Stifel 2025 Jaws and Paws Conference Conference
2025-05-22 BNP Paribas 2nd Annual Animal Health Day Event
2025-05-21 2025 Annual Meeting of Shareholders Shareholder meeting
2025-05-06 Zoetis Quarterly Corporate Performance - First Quarter 2025 Event
2025-03-11 Barclays Global Healthcare Conference Conference
2025-02-27 Bank of America Securities 2025 Animal Health Summit Event

Source: https://investor.zoetis.com/home/default.aspx

Key facts CIK 1555280 CUSIP 98978V103 13F (30d) 1132 filings 1027 filers Visit website Investor relations